The use of alpha blockers causes an increased incidence of IFIS and, with it, an increased morbidity during routine cataract surgery. We are urging a new PPP for these patients: If a urologist is considering starting a patient on an alpha blocker to treat urinary symptoms, a baseline exam from the ophthalmologist should be obtained prior to the start of treatment. If a cataract is detected, it should be removed prior to the initiation of alpha antagonist therapy. This would go a long way toward minimizing the morbidity in these patients.